NASDAQ:IBB

iShares Biotechnology ETF Stock Forecast, Price & News

$117.36

-2.76 (-2.30%)

(As of 06/28/2022 04:00 PM ET)

Add

Compare

Today's Range: $116.87
▼
$120.42
50-Day Range: $105.82
▼
$129.00
52-Week Range: $104.29
▼
$177.37

Volume: 1.82 million shs
Average Volume: 2.77 million shs
Market Capitalization: $7.53 billion

P/E Ratio: N/A
Dividend Yield: 0.27%
Price Target: N/A

30 days | 90 days | 365 days | Advanced Chart

Receive IBB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iShares Biotechnology ETF and its competitors with MarketBeat's FREE daily newsletter.

Basic Details

Issuer BlackRock

Fund NameiShares Nasdaq Biotechnology ETF

Tax ClassificationRegulated Investment Company

SymbolNASDAQ:IBB

Inception Date2/5/2001

Fund ManagerDiane Hsiung, Jennifer Hsui, Greg Savage, Alan Mason

WebN/A

PhoneN/A

Fund Focus

Asset ClassEquity

BenchmarkNASDAQ Biotechnology Index

CategorySector

FocusHealth Care

Development LevelDeveloped Markets

RegionNorth America

Fund Statistics

Assets Under Management$7.70 billion

Average Daily Volume$2.62 million

Discount/Premium0.08%

ETF Expenses

Management Fee0.47%

Other Expenses0.00%

Total Expenses0.47%

Fee Waiver0.00%

Net Expenses0.47%

Administrator, Advisor and Custodian

AdministratorState Street Bank and Trust Company

AdvisorBlackRock Fund Advisors

CustodianState Street Bank and Trust Company

DistributorBlackRock Investments, LLC

Transfer AgentState Street Bank and Trust Company

Trustee

Lead Market MakerVirtu Financial

Geographic Exposure of IBB

Currency Exposure of IBB

Sector Exposure of IBB

Industry Exposure of IBB

iShares Biotechnology ETF Frequently Asked Questions

How has iShares Biotechnology ETF's stock price performed in 2022?: iShares Biotechnology ETF's stock was trading at $152.62 on January 1st, 2022. Since then, IBB shares have decreased by 23.1% and is now trading at $117.36.
View the best growth stocks for 2022 here.
How often does iShares Biotechnology ETF pay dividends? What is the dividend yield for iShares Biotechnology ETF?: iShares Biotechnology ETF announced a quarterly dividend on Wednesday, June 8th. Shareholders of record on Friday, June 10th will be paid a dividend of $0.031 per share on Wednesday, June 15th. This represents a $0.12 dividend on an annualized basis and a dividend yield of 0.11%. The ex-dividend date is Thursday, June 9th.
View iShares Biotechnology ETF's dividend history.
Is iShares Biotechnology ETF a good dividend stock?: iShares Biotechnology ETF(NASDAQ:IBB) pays an annual dividend of $0.31 per share and currently has a dividend yield of 0.27%.
View iShares Biotechnology ETF's dividend history.
When did iShares Biotechnology ETF's stock split? How did iShares Biotechnology ETF's stock split work?: iShares Biotechnology ETF's stock split on the morning of Friday, December 1st 2017. The 3-1 split was announced on Tuesday, November 7th 2017. The newly minted shares were issued to shareholders after the closing bell on Thursday, November 30th 2017. An investor that had 100 shares of iShares Biotechnology ETF stock prior to the split would have 300 shares after the split.
Who are iShares Biotechnology ETF's key executives?: iShares Biotechnology ETF's management team includes the following people:
George G. C. Parker Ph.D., Independent Chairman of the Board of Trustees
Michael Arthur Latham, President, Trustee
Jack Gee, Chief Financial Officer, Treasurer
Geoffrey D. Flynn, Chief Operating Officer, Executive Vice President
, Bio & Compensation -
Amy Schioldager, Executive Vice President
Ira P. Shapiro, Vice President, Chief Legal Officer
Matt Tucker, Vice President
, Bio & Compensation -
Eilleen M. Clavere, Secretary
Cecilia H. Herbert, Independent Trustee
Charles A. Hurty, Independent Trustee
Who are some of iShares Biotechnology ETF's key competitors?: Some companies that are related to iShares Biotechnology ETF include SPDR Dow Jones Industrial Average ETF Trust (DIA), iShares MSCI Emerging Markets ETF (EEM), Consumer Discretionary Select Sector SPDR Fund (XLY), SPDR Bloomberg High Yield Bond ETF (JNK), SPDR Nuveen Barclays Short Term Municipal Bond ETF (SHM), SPDR Nuveen Barclays Municipal Bond ETF (TFI), DNP Select Income Fund (DNP), iShares MSCI Pacific ex Japan ETF (EPP), Nuveen Municipal Value Fund (NUV), WisdomTree Emerging Markets High Dividend Fund (DEM), Goldman Sachs BDC (GSBD), Direxion Daily Financial Bull 3X Shares (FAS), Adams Diversified Equity Fund (ADX), Hercules Capital (HTGC) and The Gabelli Equity Trust (GAB).
View all of IBB's competitors.

What other stocks do shareholders of iShares Biotechnology ETF own?: Based on aggregate information from My MarketBeat watchlists, some companies that other iShares Biotechnology ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Cisco Systems (CSCO), Micron Technology (MU), Bank of America (BAC), Johnson & Johnson (JNJ) and PayPal (PYPL).
What is iShares Biotechnology ETF's stock symbol?: iShares Biotechnology ETF trades on the NASDAQ under the ticker symbol "IBB."
Who are iShares Biotechnology ETF's major shareholders?: iShares Biotechnology ETF's stock is owned by many different institutional and retail investors. Top institutional shareholders include Bank of America Corp DE (19.42%), UBS Group AG (3.10%), Citigroup Inc. (3.03%), Goldman Sachs Group Inc. (2.42%), Royal Bank of Canada (1.97%) and JPMorgan Chase & Co. (0.98%).
Which major investors are selling iShares Biotechnology ETF stock?: IBB stock was sold by a variety of institutional investors in the last quarter, including Healthcare of Ontario Pension Plan Trust Fund, Bank Julius Baer & Co. Ltd Zurich, Jane Street Group LLC, Alpha Cubed Investments LLC, Mmbg Investment Advisors CO., Cutler Group LP, Royal Bank of Canada, and Cetera Advisor Networks LLC.
Which major investors are buying iShares Biotechnology ETF stock?: IBB stock was bought by a variety of institutional investors in the last quarter, including Bank of America Corp DE, Goldman Sachs Group Inc., Citigroup Inc., Hackensack Meridian Health Inc., UBS Group AG, JPMorgan Chase & Co., Tredje AP fonden, and Atria Wealth Solutions Inc..
How do I buy shares of iShares Biotechnology ETF?: Shares of IBB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is iShares Biotechnology ETF's stock price today?: One share of IBB stock can currently be purchased for approximately $117.36.
How much money does iShares Biotechnology ETF make?: iShares Biotechnology ETF (NASDAQ:IBB) has a market capitalization of $7.53 billion.

This page (NASDAQ:IBB) was last updated on 6/29/2022 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

MarketBeat Resources